- Research article
- Open Access
Evolution of the CDKN1C-KCNQ1 imprinted domain
BMC Evolutionary Biology volume 8, Article number: 163 (2008)
Genomic imprinting occurs in both marsupial and eutherian mammals. The CDKN1C and IGF2 genes are both imprinted and syntenic in the mouse and human, but in marsupials only IGF2 is imprinted. This study examines the evolution of features that, in eutherians, regulate CDKN1C imprinting.
Despite the absence of imprinting, CDKN1C protein was present in the tammar wallaby placenta. Genomic analysis of the tammar region confirmed that CDKN1C is syntenic with IGF2. However, there are fewer LTR and DNA elements in the region and in intron 9 of KCNQ1. In addition there are fewer LINEs in the tammar compared with human and mouse. While the CpG island in intron 10 of KCNQ1 and promoter elements could not be detected, the antisense transcript KCNQ1OT1 that regulates CDKN1C imprinting in human and mouse is still expressed.
CDKN1C has a conserved function, likely antagonistic to IGF2, in the mammalian placenta that preceded its acquisition of imprinting. CDKN1C resides in synteny with IGF2, demonstrating that imprinting of the two genes did not occur concurrently to balance maternal and paternal influences on the growth of the placenta. The expression of KCNQ1OT1 in the absence of CDKN1C imprinting suggests that antisense transcription at this locus preceded imprinting of this domain. These findings demonstrate the stepwise accumulation of control mechanisms within imprinted domains and show that CDKN1C imprinting cannot be due to its synteny with IGF2 or with its placental expression in mammals.
Eutherians and marsupials (therian mammals) diverged between 125–145 million years ago [1–3]. Genomic imprinting, in which the monoallelic expression of certain genes depends on the parent of origin, occurs in both therian mammal lineages. This is in contrast to all other vertebrate species including monotreme mammals in which imprinting of endogenous genes has not been demonstrated [4–7]. Monoallelic expression negates the advantage of diploidy, namely the masking of deleterious alleles. The cost of imprinting must, therefore, be outweighed by its potential benefits to the genetic fitness of the individual. The parental conflict hypothesis proposes that imprinting is the product of asymmetric selection on parental genomes, with selection favouring the expression of paternal genes that increase the amount of maternal nutrient transfer while expression from maternally-inherited genes will be favoured if they reduce nutritional demands on the mother [8–10]. The placentas of marsupials and eutherians mediate the transfer of nutrients between mother and young and the placentas of both groups of mammal express imprinted genes [11–16]. However, the marsupial placenta is comparatively short-lived and the majority of support for growth and development of the marsupial young occurs during an extended and complex period of lactation . Thus marsupials are ideal models in which to examine the evolution of imprinting and its association with mammalian placentation.
CDKN1C (expressed from the maternally inherited allele) and IGF2 (expressed from the paternally inherited allele) are syntenic, and implicated in growth disorders such as Beckwith-Wiedemann syndrome . IGF2 is paternally expressed in mouse and human  and stimulates cell cycle progression. IGF2 is highly conserved in all vertebrates and is expressed during marsupial placentation, as it in the eutherian placenta . IGF2 is also imprinted in the tammar placenta, indicating imprinting at this locus evolved before the eutherian-marsupial split . In contrast, progression through the cell cycle is negatively controlled by cyclin-dependent kinase (CDK) inhibitors, such as p57KIP2, encoded by the gene CDKN1C [20–22]. CDKN1C is expressed from the maternal allele in many tissues of mouse and human, including the placenta [23, 24], but is bi-alellically expressed (ie, not imprinted) in the tammar wallaby . Placental development is disrupted in mice carrying a maternally-derived mutation in Cdkn1c [18, 25] and mutations in CDKN1C are associated with trophoblastic disease in humans [26, 27]. Unlike IGF2, CDKN1C is rapidly evolving in mammals and has low homology between mouse, human, and tammar, with only the CDK-inhibiting domain conserved [14, 28]. Divergence in the structure of p57KIP2 suggests functional specialisation in different species and may explain species-specific patterns of expression, subtle differences in the pathologies of human and mouse CDKN1C mutants , and the absence of imprinting of this gene in the tammar .
Most imprinted genes aggregate within the genome and in each imprinted domain gene order and imprint status show considerable similarity between mouse and human [30–32]. IGF2 and CDKN1C are syntenic, and reside in an imprinted cluster on mouse distal chromosome 7. Included in this region are the maternally expressed genes Ipl/Tssc3, Slc22a1l/Tssc4, Mash2/Ascl2, and Cdkn1c and the paternally expressed genes Igf2 and Ins2. Gene order and the imprint status of most genes within this region are conserved with human chromosome 11p15.5 . The entire region is regulated by two differentially methylated imprinting control regions (ICRs) one of which is the KCNQ1OT1 antisense-RNA transcript, that regulates the expression of Cdkn1c, Kcnq1, and Ascl2 [31, 32]. Conserved synteny may reflect the co-ordinated transcriptional regulation of several imprinted genes within each domain [34, 35]. The IGF2-CDKN1C region is highly conserved even between human and chicken, despite a lack of imprinting in the chicken . Nevertheless, synteny may facilitate the co-evolution of maternal and paternal imprints in adjacent regions of the genome [35, 37], possibly by the spread of imprinting mechanisms from one locus to another, as described by the bystander hypothesis . INS and IGF2 are syntenous in mouse, human and tammar [15, 39, 40]. Extension of this synteny from IGF2 to CDKN1C has recently been described in marsupials . This is of particular importance given that IGF2 and INS are imprinted in the tammar, as in mouse and human, but CDKN1C is not [14, 15].
Differentially methylated regions (DMRs), often found at CpG islands in or near imprinted genes, clearly contribute to the regulation of imprinted expression in eutherians [34, 41–43]. However, not all imprinted genes depend on this mechanism. Antisense transcripts and various forms of chromatin modification also regulate imprinted expression in eutherians [44–46]. Kcnq1ot1 (LIT1) is a paternally expressed antisense transcript originating from intron 10 of the maternally expressed Kcnq1 (KvLQT1) gene [47, 48]. The human KCNQ1OT1 promoter starts approximately 40 bp upstream of the transcription initiation site and spans 300 to 350 bp , although associated transcription factor binding sites may extend as far as 2000 bp upstream [36, 47]. The transcription initiation site is located in a CpG island that is methylated in oocytes, but not in sperm. Methylation blocks transcription of the maternal allele of Kcnq1ot1 and deletion of either the CpG island or Kcnq1ot1 increases expression of Cdkn1c, Kcnq1, and Ascl2, indicating its role in the coordinated regulation of these loci .
DNA methylation as a regulator of imprinted expression may have evolved from the molecular systems associated with the silencing of transposable elements. The host defence hypothesis suggests that DNA methylation fortuitously provided a mechanism to regulate parental specific gene expression and similar circumstances may have led to the silencing function of antisense transcripts at imprinted loci [50, 51]. Indeed, many imprinted genes are found in association with repeat sequences such as non-LTR elements (long and short interspersed transposable elements – LINEs/SINEs), DNA elements, and endogenous retroviruses [37, 52–54] and are all known to attract methylation .
We determined the expression of CDKN1C and the cellular localisation of its protein, p57KIP2, in the placenta of the tammar wallaby because of their evolutionary divergence from eutherian mammals. We examined whether CDKN1C became imprinted after it acquired a role in placental development, or if its placental expression pre-dated the evolution of its imprinting. In addition, to gain insight into the evolution of imprinting within this cluster, the structure and repeat distribution of the CDKN1C domain, including KCNQ1 and the ICR, KCNQ1OT1, were investigated in the tammar.
P57KIP2localises to the tammar placenta
While CDKN1C is imprinted in eutherians and vital for placentation, it is not imprinted in the tammar . The chorio-vitelline placenta of the tammar (Macropus eugenii) consists of two functional regions, a vascular and non-vascular one. The vascular, trilaminar placenta is thought to be the primary site of gas exchange, while that of the avascular, bilaminar region, the predominant site for nutritional exchange [55, 56]. We used immunohistochemistry to examine P57KIP2 in both regions of the marsupial placenta. P57KIP2 was localised in the cytoplasm and nucleus of all cell types in the bilaminar and trilaminar yolk sac placenta (Figure 1). However, while the protein was consistently present in many cells of the yolk sac endoderm and trophoblast, staining in the mesenchymal and endothelial cells was sporadic (Figure 1). No notable difference in staining intensity or in the cross-reactivity of different cell types was evident for the stages examined (days 19–26 of the 26.5 day gestation). Weak non-specific cytoplasmic staining was evident in the yolk sac endoderm and, to a lesser extent, the trophoblast in matched goat IgG treated controls (Figure 1), but was clearly distinguishable from the dense staining in both the cytoplasm and nucleus with p57Kip2 Ab-7. There was no cytoplasmic or nuclear staining in no-antibody negative controls (not shown).
CDKN1C expression increases in the final days of gestation
CDKN1C was expressed in the tammar placenta, but immunohistochemistry did not indicate if there were changes in the quantity of protein over time. We used quantitative RT-PCR to examine quantitative changes in the expression of CDKN1C. Between days 19 and 24, CDKN1C expression was higher in the trilaminar yolk sac than in the bilaminar yolk sac placenta (Bonferroni adjusted paired t-test, n ≥ 5, α ≤ 0.039) (Figure 2). However, in the two days before birth (days 25 and 26) there was no longer a significant difference in CDKN1C expression between vascular and avascular regions (Bonferroni adjusted paired t-test, n = 5, α = 0.158), but there was a significant increase in CDKN1C expression in both regions of the placenta (Bonferroni adjusted unpaired t-test, n ≥ 5, α ≤ 0.043).
Genomic analysis – gene order is conserved in the tammar and eutherians
We examined the region containing IGF2 and CDKN1C in the tammar and compared this to human and mouse. A BLAST-N with tammar CDKN1C sequence identified a single clone of tammar genomic DNA (GenBank: CU041371.1, clone MEKBa-36303). Successive BLAST-N searches identified five more overlapping clones joining the IGF2-contianing clone to the CDKN1C-containing clone [Genbank: CR925759.7, Genbank: CR848708.12, Genbank: CU024874.2, Genbank: CU024865.1, Genbank: CU311200.1] (Figure 3A). Each set of overlapping clones showed 100% identity over at least 1000 bp. The overlapping clones provided almost 1 Mb of continuous sequence spanning the domains bordered by IGF2 and CDKN1C.
Several regions were conserved or homologous between human, mouse, and tammar as indicated by a multi-species percent identity plot (PIP) (Figure 3B). Most of the conserved regions corresponded to genomic locations with a high gene density, such as the gene cluster bordered by ASCL2 and TRPM5. However, the large intergenic region between TH and ASCL2 also had two regions conserved or homologous in all three species (see Genomic Analysis below).
A PIP of the orthologous region of human against the tammar sequence was generated. Regions of high homology to human indicated the location of putative exons in the tammar sequence. The sequence of each possible exon was entered into a BLASTN to confirm gene identity and was aligned back to human sequences to confirm the location of exon-intron boundaries (data not shown). Of the nine genes located between IGF2 and CDKN1C in human, eight were identified in the tammar with KCNQ1OT1 the only gene not found by homology (Figure 3C). Exons homologous to human TSSC5, which lies downstream of CDKN1C, were also identified, but the partial sequence available did not extend to cover the entire gene.
Gene order was highly conserved between human, mouse, and tammar (Figure 3C), as was gene structure. A multi-species PIP of the KCNQ1 gene of human against mouse, tammar, and chicken, shows conserved gene structure in all four species, with regions of homology corresponding to exon locations (Figure 4A). However, while the exon-intron structure of KCNQ1 was generally highly conserved, intron 4 was absent in chicken and intron 9 was significantly reduced in length in the tammar and in chicken (Figure 4B). In mouse and human the KCNQ1OT1 transcript starts in intron 10 and extends into intron 9. Mouse intron 9 and 10 of KCNQ1 had significant homology with human introns 9 and 10, while no homology was evident for the tammar or chicken (Figure 5A).
Genomic analysis – Tammar sequences lack the KCNQ1OT1 promoter and CpG island
The CpG island in intron 10 of KCNQ1 is essential for imprinted expression of the KCNQ1OT1 transcript in mouse and human. We examined the CpG content of the orthologous region in the tammar. There were 24 CpG islands, grouped into nine clusters, in the sequence spanning IGF2 to CDKN1C in the tammar, while in human there were 51 (in 31 clusters) and in mouse 29 (in 12 clusters, Figure 3C). Six CpG islands in the human sequence were greater than 1000 bp in length with the longest island 2671 bp. In comparison, only one of the islands in the tammar sequence was longer than 1000 bp (1373 bp). However, mouse also had only two CpG islands over 1000 bp (the longest reaching 1025 bp). Although both human and mouse had fewer CpG islands in KCNQ1 compared to the remaining sequence assessed (see IGF2-CDKN1C in Figure 3C), there were no CpG islands in KCNQ1 of the tammar (Figure 4B). Like human and mouse, chicken had a CpG island in KCNQ1 (Figure 4B). Despite differences in the CpG island content of KCNQ1 in the human and tammar, the overall percent GC was similar (50.9% in the tammar and 51.4% in human).
In human, mouse and chicken at least one CpG island was located in intron 10 of KCNQ1 (Figure 5B). In human and mouse the position of the CpG island and the KCNQ1OT1 promoter region were highly conserved (Figure 5A and 5B). Although a CpG island was also present in the chicken intron 10, it is not clear if this is orthologous, as no significant homology to the KCNQ1OT1 transcription start site could be found, and the CpG island was located approximately 20 and 15 Kb downstream of the orthologous CpG islands in human and mouse respectively.
Expression analysis of KCNQ1O1
Primers were designed within the tammar KCNQ1 intron 10 to determine if it still encoded a KCNQ1OT1 antisense RNA molecule despite its lack of conservation with human and mouse. Since primers did not span an intron, extracted RNA was DNased and an aliquot removed for PCR to ensure there was no genomic DNA contamination (RT- control). Surprisingly, transcription of the putative KCNQ1O1 gene was detected in the trilaminar, but not the bilaminar placenta and only during the final stages of pregnancy (Figure 6). The resulting PCR band was sequence verified to ensure amplification of the correct product.
Genomic analysis – Analysis of repeat distribution in the IGF2-CDKN1C region
Repeat sequences may contribute to the evolution and or regulation of many imprinted regions and so the distribution of repetitive elements in the tammar IGF2-CDKNIC region was assessed. Two regions of high homology were identified in the intergenic DNA between TH and ASCL2 (Figure 3B) and represent areas of high LINE/SINE density in all three species (Figure 3C).
The percent sequence covered by all repetitive elements in the region from IGF2-CDKN1C was not significantly different between species (Figure 7A). When the KCNQ1 region was assessed separately, the percent covered by all repetitive sequences in introns 1, 1b, 9, 10, and 14 (the largest introns) still did not differ significantly between species. However, the percentage of sequenced covered by specific classes of repetitive sequence did differ significantly between species (Figure 7A).
There were significantly fewer long-terminal repeat (LTR) elements (GLM; α = 0.000) and DNA elements (GLM; α = 0.001) in tammar KCNQ1 introns 1, 1b, 9, 10, and 14 compared to the same introns in mouse and human, while there were significantly more low complexity regions (α = 0.000). However, the lower percentage of sequence covered by LTR and DNA elements in the tammar compared to mouse and human was also evident across the entire region from IGF2 to CDKN1C (Figure 3C, 4B, and 7A). However, the relative proportion of LINE/SINEs and simple repeats was not notably different between species in either KCNQ1 or the entire IGF2-CDKN1C region (Figure 3C and 7A).
In both human and mouse there was high concentration of repetitive elements in intron 9, largely due to an increase in LINEs, which are largely absent in tammar intron 9 (Figure 4B and 7B). This was significantly different in mouse compared to tammar (Grubb's critical = 1.71; n = 5; z value = 1.785), but not with human (Grubb's critical = 1.71; n = 5; z value = 1.646). A decrease in SINEs is associated with imprinted regions . However, there was no significant difference in the percentage of sequence covered by SINEs between tammar and human and mouse.
Despite similarities in the overall proportions of different types of repetitive elements in mouse and human, no specific repetitive elements in intron 9, intron 10, or at the transcription start site, were clearly identified as homologous (Figure 5B). However, in both human and mouse an L1MB element (L1MB8 in human and L1MB7 in mouse) was located approximately 10 to 15 Kb upstream of the KCNQ1OT1 transcription start site (Figure 5B).
We have confirmed the synteny of CDKN1C with IGF2 in the tammar wallaby and shown it is highly conserved between the human, mouse and tammar. IGF2 and p57KIP2 antagonistically regulate growth of the eutherian placenta. Although CDKN1C is not imprinted in the tammar wallaby, it is expressed in the placenta and so could antagonise the growth promoting effects of IGF2 on the marsupial placenta. Furthermore, the antisense transcript, KCNQ1OT1, known to regulate CDKN1C imprinting in eutherians is also expressed in the marsupial placenta. However, a CpG island and promoter, orthologous to eutherian KCNQ1OT1, were absent in the tammar genome. These data suggest that imprinting of the CDKN1C gene is not contingent on its synteny with IGF2, expression in the placenta or the expression of the KCNQ1OT1 gene.
The p57KIP2 protein was present in the trophoblast, yolk sac endoderm, and some mesenchymal cells of the yolk sac placenta. In eutherians, P57KIP2 binds cyclin-dependent kinases in the nucleus. In the tammar, P57KIP2 was found in the nucleus as well as the cytoplasm of cells in all tissue types, suggesting that this protein is functional in the marsupial placenta, as in eutherians. However, members of the KIP family, including p57KIP2, also have roles outside their CDK activity that may account for their cytoplasmic location [57–60].
CDKN1C mRNA expression was higher in the trilaminar placenta compared to the bilaminar, but this difference was only significant when expression was low (days 22 to 24). More conspicuous was the significant increase in CDKN1C expression in both regions of the yolk sac placenta in the two days before birth (days 25 to 26). The vascular region of the placenta develops rapidly between days 19–24 to facilitate transfer of nutrients to the developing fetus, consistent with a low CDKN1C expression. The increase in CDKN1C expression immediately before birth is consistent with retarded growth of the placenta at this time . The slightly higher expression of CDKN1C in the trilaminar placenta may represent the terminal differentiation of haematopoietic tissue in this region that requires exit from the cell cycle. CDKN1C expression in the marsupial placenta is therefore consistent with a role for P57KIP2 in the inhibition of cell cycle progression and regulation of marsupial placental growth.
IGF2 and CDKN1C are co-expressed in the placentas of human, mouse, and tammar, suggesting these genes were also co-expressed in the placenta of the therian ancestor. The antagonistic functional relationship between these genes is also likely to have existed in the ancestor of marsupials and eutherians. However, the CDKN1C imprint must have been acquired later and only in the eutherian lineage .
All genes located between IGF2 and CDKN1C in human were also syntenic in the tammar. However, homology to KCNQ1OT1 was lacking. Despite high conservation of KCNQT1 exons between mouse, human and tammar, intron 10 of the tammar KCNQT1 gene showed no homology to the KCNQ1OT1 eutherian transcript. The promoter region and associated CpG island, conserved in human and mouse , could not be detected in the tammar. Intron 9 of KCNQ1, which encodes the terminal end of KCNQ1OT1, also lacks homology with its eutherian counterpart and is considerably shorter in the tammar (and chicken) than in human and mouse. Since KCNQ1OT is a non-coding RNA transcript, its sequence conservation with eutherians is not critical to its function . We therefore examined the expression of KCNQT1 intron 10 by RT-PCR. Despite the sequence divergence, transcription was detected suggesting that an antisense RNA KCNQ1OT1-orthologue exists in marsupials as in eutherians. This is especially interesting, since CDKN1C is not imprinted in marsupials, despite the presence of KCNQ1OT1. It will be important to determine whether KCNQ1 and KCNQ1OT1 are imprinted in the tammar, as in eutherians. As none of the promoter elements of eutherian KCNQ1OT1 were identified, it is possible that marsupial KCNQ1OT1 is regulated by a completely different means and has not yet been co-opted into regulating imprinting of CDKN1C. However, it does show that evolution of KCNQ1OT1 preceded imprinting of CDKN1C.
Throughout the rest of the IGF2-CDKN1C region, there was little cross-species sequence homology in the intergenic regions. However, two regions of high homology were identified in mammals between the TH and ASCL2 genes. Both sites of homology corresponded to regions of high LINE/SINE density suggesting conservation of repetitive elements may account for the sequence homology, rather than any regulatory or control regions. These repeats may be important for establishing a boundary region between two independently regulated domains, leading to their conservation.
There were significantly fewer DNA elements and endogenous retroviruses (LTR elements) across the entire region, spanning both the imprinted IGF2 domain and the non-imprinted CDKN1C domain. However, in both mouse and human there was a considerable increase in repetitive elements in intron 9, when compared with the tammar. This was due to the accumulation of LINEs that appear to coincide with the termination of the KCNQ1OT1 transcript. These results suggest that the truncation of KCNQ1 intron 9 in the tammar and the increase in LINEs in mouse and human may be associated with the evolution of KCNQ1 imprinting in the region.
Despite its lack of imprinting, marsupial CDKN1C is expressed in the developing placenta where it may antagonise the actions of IGF2 on cell-cycle progression, as it does in eutherians. Since CDKN1C resides in synteny with IGF2, imprinting of the two genes did not occur concurrently to balance maternal and paternal influences on the growth of the placenta. The expression of KCNQ1OT1 in the absence of CDKN1C imprinting suggests that antisense transcription at this locus may have preceded imprinting of this domain. These findings demonstrate the stepwise accumulation of control mechanisms within imprinted domains and show that CDKN1C imprinting is not due to its synteny with IGF2 or its placental expression in mammals.
Adult females carrying fetuses in the final third of gestation (day 19 to day 26 of a 26.5 day gestation)  were euthanised either by cervical dislocation or by an anaesthetic overdose (sodium pentobarbitone, 60 mg/ml, to effect) and portions of the bilaminar (BYS) and trilaminar (TYS) yolk sac placenta collected as previously described [55, 62]. All experiments were approved by the University of Melbourne Animal Experimentation Ethics Committees and the animal handling and husbandry were in accordance with the CSIRO/Australian Bureau of Agriculture and National Health and Medical Research Council of Australia (1990) guidelines.
Small pieces of uterus with placenta attached were collected from days 19–21, 22–24, and 25–26 of pregnancy and fixed in 4% PFA before paraffin embedding. After sectioning at 7 μm, dewaxing and rehydration, an antigen retrieval step of 90°C for 60 min in 10 mM sodium citrate buffer pH 6.0 was performed. A rabbit polyclonal p57Kip2 Ab-7 antibody (NeoMarkers, RB-1637-P0) was used to localise p57KIP2 in the yolk sac. The antibody epitope corresponded to the C-terminus, which is conserved in marsupial and eutherian p57KIP2 proteins . Sections were blocked with 10% normal goat serum/TBS/1% BSA for 25 minutes at room temperature and subsequently incubated overnight at 4°C with the primary antibody (0.004 g/L). IgG antibody (Santa Cruz, normal rabbit IgG, # sc-2027) negative controls (0.004 g/L) and no-antibody (diluent only) negative controls were run concurrently with the p57Kip2 Ab-7 antibody. A biotinylated secondary antibody, goat anti-rabbit (DAKO, # E0432), was used with ABComplex/HRP kit (DAKO, # K0355) and colour developed with DAB Chromagen tablets (DAKO, # S3000). Sections were counterstained in haematoxylin. Sections from each individual were treated in at least two independent immunohistochemical runs to assess the consistency of staining.
Approximately 300 ng of total RNA (GenElute Mammalian Total RNA Kit, Sigma, # RTN70) was DNase treated (DNA-free, Ambion, # 1906) and an aliquot removed (designated the RT- control) prior to an oligo (dT)12–18primed cDNA synthesis reaction (SuperScript First Strand Synthesis System for RT-PCR, Invitrogen, # 11904-018) (designated RT+ reactions). PCRs, with primers designed within intron 10 of the KCNQ1 gene (Fwd 5'-TTCTGCTGGTTCAGCATCAC; Rev 5'-GATGGGAGGGAAGGACATTT;
PCR conditions consisted of: 95°C for 2 mins, followed by 40 cycles of: 95°C for 30 s, 60°C for 30 s, 72°C for 1 min), were performed on RT- and RT+ samples to control for the complete absence of contaminating genomic DNA carryover. Resulting products were sequenced to verified correct product amplification.
Approximately 300 ng of DNase treated (DNA-free, Ambion, # 1906) total RNA (GenElute Mammalian Total RNA Kit, Sigma, # RTN70) was used in an Oligo (dT)12–18 primed cDNA synthesis reaction (SuperScript First Strand Synthesis System for RT-PCR, Invitrogen, # 11904-018). SYBR green (Quantitect, # 204143) was used in a quantitative PCR on the MJ Research Opticon 2. Primer sequences and PCR conditions are given in Table 1. Melting curve analysis and agarose gel electrophoresis ensured a single product. B-ACT was used as a calibrator and endogenous gene control (forward primer 5' GATCCATTGGAGGGCAAGTCT 3' and reverse primer 5' CCAAGATCCAACTACGAGCTTTTT 3'). Standard curves confirmed linearity over three orders of magnitude of yolk sac cDNA dilutions. Reactions were performed in triplicate and the data exported into Microsoft Excel and Systat for analysis. The standard curve showed linearity over three orders of magnitude of yolk sac cDNA dilutions, indicating that the primers work over a range of cDNA concentrations and had a correlation co-efficient of 0.999. The standard deviation of CT values amongst triplicates ranged from 0.01 to 0.99 indicating that within each triplicate CT values were within 1 cycle of each other.
A partial cDNA sequence of tammar CDKN1C (Suzuki et al., 2005) was used in a BLAST-N (NCBI;  to identify a BAC clone of tammar genomic DNA. Overlapping clones were identified by successive BLAST-Ns of the terminal 1000 – 3000 bp of each new clone. All human, mouse, and chicken sequences were obtained from Ensembl . Sequences were examined for CpG islands (EMBOSS CpG Plot; ). CpG islands were searched using default settings (200 bp with a CG percentage greater than 50% for a 10 window set and an observed over expected of 0.6).
Repetitive elements were searched using species-specific databases available as option settings in RepeatMasker  and Censor [67, 68]. However, Monodelphis domestica was used in analysis of Macropus eugenii when performing a Censor search and, for RepeatFinder, the Mammalian repeat database was searched as no specific marsupial repeat databases were available. Repeat sequences were assessed in the region from IGF2 to CDKN1C as a single unit and in all large introns of KCNQ1 (introns 1, 1b, 9, 10, and 14), each as single units. Only large introns were assessed as smaller introns have fewer repetitive elements of all types and, as such, comparisons between introns 9 and 10 where assessed against similarly sized introns.
Percent identity plots (PIPMaker and MultiPIPMaker:  were used to identify conserved and homologous regions between species and to locate putative exons in the tammar. BLASTN (NCBI tools) and ClustalW (EBI tools; ) were used to confirm the identity of genes/exons. KCNQ1OT1 (intron 10 of KCNQ1) was assessed with mVISTA  to identify sequence homology within the putative promoter region. The percent sequence conservation, which refers to number of sequences with 70% homology over at least 100 bp.
Univariate statistics (means, variation) and Grubbs' test for outliers were performed using Microsoft Excel (version Microsoft XP 2003). Analysis of quantitative gene expression followed standard procedures [72, 73]. Paired (BYS versus TYS) and unpaired (comparisons between stages) t-tests were Bonferroni adjusted (using Systat Version 10.2) to correct for multiple comparisons. The percent coverage of different types of repetitive elements was arcsine transformed and differences between species assessed by general liner model (GLM) least squares analyses using Systat Version 10.2. Grubbs' test for outliers was used to assess if the percent sequence coverage of each element was significantly different in one intron compared to all other similarly sized introns. Quantitative data are presented as means ± s.e.m. for quantitative RT-PCR or as box plots or stacked column graphs for repeat sequence data. Statistical significance was at the 5% level (α-value less than 0.05).
bilaminar yolk sac placenta
trilaminar yolk sac placenta
- CDKN1C :
cyclin dependent kinase inhibitor 1C
- IGF2 :
insulin-like growth factor 2
- INS :
- KCNQ1 :
Potassium channel, voltage-gated, KQT-like subfamily, member 1
- KCNQ1OT1 KCNQ1 :
overlapping transcript 1
long interspersed element
long terminal repeat
short interspersed element.
Luo ZX, Ji Q, Wible JR, Yuan CX: An Early Cretaceous tribosphenic mammal and metatherian evolution. Science. 2003, 302 (5652): 1934-40. 10.1126/science.1090718.
Bininda-Emonds OR, Cardillo M, Jones KE, et al: The delayed rise of present-day mammals. Nature. 2007, 446 (7135): 507-12. 10.1038/nature05634.
Wible JR, Rougier GW, Novacek MJ, Asher RJ: Cretaceous eutherians and Laurasian origin for placental mammals near the K/T boundary. Nature. 2007, 447 (7147): 1003-6. 10.1038/nature05854.
Killian JK, Byrd JC, Jirtle JV, et al: M6P/IGF2R imprinting evolution in mammals. Mol Cell. 2000, 5 (4): 707-16. 10.1016/S1097-2765(00)80249-X.
Killian JK, Nolan CM, Stewart N, et al: Monotreme IGF2 expression and ancestral origin of genomic imprinting. J ExpZool. 2001, 291 (2): 205-12.
O'Neill MJ, Ingram RS, Vrana PB, Tilghman SM: Allelic expression of IGF2 in marsupials and birds. Dev Genes Evol. 2000, 210 (1): 18-20. 10.1007/PL00008182.
Lawton BR, Sevigny L, Obergfell C, Reznick D, O'Neill RJ, O'Neill MJ: Allelic expression of IGF2 in live-bearing, matrotrophic fishes. Dev Genes Evol. 2005, 215 (4): 207-12. 10.1007/s00427-004-0463-8.
Haig D: Parental antagonism, relatedness asymmetries, and genomic imprinting. Proc Biol Sci. 1997, 264 (1388): 1657-62. 10.1098/rspb.1997.0230.
Haig D, Graham C: Genomic imprinting and the strange case of the insulin-like growth factor II receptor. Cell. 1991, 64 (6): 1045-6. 10.1016/0092-8674(91)90256-X.
Moore T, Haig D: Genomic imprinting in mammalian development: a parental tug-of-war. Trends Genet. 1991, 7 (2): 45-9. 10.1016/0168-9525(91)90230-N.
Georgiades P, Watkins M, Burton GJ, Ferguson-Smith AC: Roles for genomic imprinting and the zygotic genome in placental development. Proc Natl Acad Sci USA. 2001, 98 (8): 4522-7. 10.1073/pnas.081540898.
Coan PM, Burton GJ, Ferguson-Smith AC: Imprinted genes in the placenta-a review. Placenta. 2005, 26 (Suppl A): S10-20. 10.1016/j.placenta.2004.12.009.
Morison IM, Ramsay JP, Spencer HG: A census of mammalianimprinting. Trends Genet. 2005, 21 (8): 457-65. 10.1016/j.tig.2005.06.008.
Suzuki S, Renfree MB, Pask AJ, et al: Genomic imprinting of IGF2, p57(KIP2) and PEG1/MEST in a marsupial, the tammar wallaby. Mech Dev. 2005, 122 (2): 213-22. 10.1016/j.mod.2004.10.003.
Ager EI, Suzuki S, Pask AJ, Shaw G, Ishino F, Renfree MB: Insulin is imprinted in the placenta of the marsupial, Macropus eugenii. Developmental Biology.
Suzuki S, Ono R, Narita T, et al: Retrotransposon Silencing by DNA Methylation Can Drive Mammalian Genomic Imprinting. PLoSGenet. 2007, 3 (4): e55-
Renfree MB: Endocrinology of pregnancy, parturition and lactation of marsupials. Marshall's Physiology of Reproduction. Pregnancy and lactation. Edited by: Lamming GE. 1994, London: Chapman & Hall, 3: 677-766. 4
Caspary T, Cleary MA, Perlman EJ, Zhang P, Elledge SJ, Tilghman SM: Oppositely imprinted genes p57(Kip2) and igf2 interact in a mouse model for Beckwith-Wiedemann syndrome. Genes Dev. 1999, 13 (23): 3115-24. 10.1101/gad.13.23.3115.
DeChiara TM, Robertson EJ, Efstratiadis A: Parental imprinting of the mouse insulin-like growth factor II gene. Cell. 1991, 64 (4): 849-59. 10.1016/0092-8674(91)90513-X.
Yan Y, Frisen J, Lee MH, Massague J, Barbacid M: Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev. 1997, 11 (8): 973-83. 10.1101/gad.11.8.973.
Gomez Lahoz E, Liegeois NJ, Zhang P, et al: Cyclin D- and E-dependent kinases and the p57(KIP2) inhibitor: cooperative interactions in vivo. Mol Cell Biol. 1999, 19 (1): 353-63.
Dyer MA, Cepko CL: p57(Kip2) regulates progenitor cell proliferation and amacrine interneuron development in the mouse retina. Development. 2000, 127 (16): 3593-605.
Hatada I, Mukai T: Genomic imprinting of p57KIP2, a cyclin-dependent kinase inhibitor, in mouse. Nat Genet. 1995, 11 (2): 204-6. 10.1038/ng1095-204.
Matsuoka S, Thompson JS, Edwards MC, et al: Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15. Proc Natl Acad Sci USA. 1996, 93 (7): 3026-30. 10.1073/pnas.93.7.3026.
Takahashi K, Kobayashi T, Kanayama N: p57(Kip2) regulates the proper development of labyrinthine and spongiotrophoblasts. Mol Hum Reprod. 2000, 6 (11): 1019-25. 10.1093/molehr/6.11.1019.
Kanayama N, Takahashi K, Matsuura T, et al: Deficiency in p57Kip2 expression induces preeclampsia-like symptoms in mice. Mol Hum Reprod. 2002, 8 (12): 1129-35. 10.1093/molehr/8.12.1129.
Fukunaga M: Immunohistochemical characterization of p57Kip2 expression in tetraploid hydropic placentas. Arch Pathol Lab Med. 2004, 128 (8): 897-900.
Lee MH, Reynisdottir I, Massague J: Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev. 1995, 9 (6): 639-49. 10.1101/gad.9.6.639.
Grandjean V, Smith J, Schofield PN, Ferguson-Smith AC: Increased IGF-II protein affects p57kip2 expression in vivo and in vitro: implications for Beckwith-Wiedemann syndrome. Proc Natl Acad Sci USA. 2000, 97 (10): 5279-84. 10.1073/pnas.080409297.
Taniguchi T, Okamoto K, Reeve AE: Human p57(KIP2) defines a new imprinted domain on chromosome 11p but is not a tumour suppressor gene in Wilms tumour. Oncogene. 1997, 14 (10): 1201-6. 10.1038/sj.onc.1200934.
Engemann S, Strodicke M, Paulsen M, et al: Sequence and functional comparison in the Beckwith-Wiedemann region: implications for a novel imprinting centre and extended imprinting. Hum Mol Genet. 2000, 9 (18): 2691-706. 10.1093/hmg/9.18.2691.
Astuti D, Latif F, Wagner K, et al: Epigenetic alteration at the DLK1-GTL2 imprinted domain in human neoplasia: analysis of neuroblastoma, phaeochromocytoma and Wilms' tumour. Br J Cancer. 2005, 92 (8): 1574-80. 10.1038/sj.bjc.6602478.
Monk D, Arnaud P, Apostolidou S, et al: Limited evolutionary conservation of imprinting in the human placenta. Proc Natl Acad Sci USA. 2006, 103 (17): 6623-8. 10.1073/pnas.0511031103.
Constancia M, Pickard B, Kelsey G, Reik W: Imprinting mechanisms. Genome Res. 1998, 8 (9): 881-900.
Reik W, Constancia M, Fowden A, et al: Regulation of supply and demand for maternal nutrients in mammals by imprinted genes. J Physiol. 2003, 547 (Pt 1): 35-44. 10.1113/jphysiol.2002.033274.
Paulsen M, Khare T, Burgard C, Tierling S, Walter J: Evolution of the Beckwith-Wiedemann syndrome region in vertebrates. Genome Res. 2005, 15 (1): 146-53. 10.1101/gr.2689805.
Kaneko-Ishino T, Kohda T, Ono R, Ishino F: Complementation hypothesis: the necessity of a monoallelic gene expression mechanism in mammalian development. Cytogenet Genome Res. 2006, 113 (1–4): 24-30. 10.1159/000090811.
Varmuza S, Mann M: Genomic imprinting – defusing the ovarian time bomb. Trends Genet. 1994, 10 (4): 118-23. 10.1016/0168-9525(94)90212-7.
Harper ME, Ullrich A, Saunders GF: Localization of the human insulin gene to the distal end of the short arm of chromosome 11. Proc Natl Acad Sci USA. 1981, 78 (7): 4458-60. 10.1073/pnas.78.7.4458.
Jones JM, Meisler MH, Seldin MF, Lee BK, Eicher EM: Localization of insulin-2 (Ins-2) and the obesity mutant tubby (tub) to distinct regions of mouse chromosome 7. Genomics. 1992, 14 (1): 197-9. 10.1016/S0888-7543(05)80308-8.
Rakyan VK, Preis J, Morgan HD, Whitelaw E: The marks, mechanisms and memory of epigenetic states in mammals. Biochem J. 2001, 356 (Pt 1): 1-10. 10.1042/0264-6021:3560001.
Reik W, Dean W: DNA methylation and mammalian epigenetics. Electrophoresis. 2001, 22 (14): 2838-43. 10.1002/1522-2683(200108)22:14<2838::AID-ELPS2838>3.0.CO;2-M.
Lucifero D, Mertineit C, Clarke HJ, Bestor TH, Trasler JM: Methylation dynamics of imprinted genes in mouse germ cells. Genomics. 2002, 79 (4): 530-8. 10.1006/geno.2002.6732.
Feil R, Khosla S: Genomic imprinting in mammals: an interplay between chromatin and DNA methylation?. Trends Genet. 1999, 15 (11): 431-5. 10.1016/S0168-9525(99)01822-3.
Grandjean V, O'Neill L, Sado T, Turner B, Ferguson-Smith A: Relationship between DNA methylation, histone H4 acetylation and gene expression in the mouse imprinted Igf2-H19 domain. FEBS Lett. 2001, 488 (3): 165-9. 10.1016/S0014-5793(00)02349-8.
Pennisi E: Behind the scenes of gene expression. Science. 2001, 293 (5532): 1064-7. 10.1126/science.293.5532.1064.
Mancini-DiNardo D, Steele SJ, Ingram RS, Tilghman SM: A differentially methylated region within the gene Kcnq1 functions as an imprinted promoter and silencer. Hum Mol Genet. 2003, 12 (3): 283-94. 10.1093/hmg/ddg024.
Mancini-DiNardo D, Steele SJ, Levorse JM, Ingram RS, Tilghman SM: Elongation of the Kcnq1ot1 transcript is required for genomic imprinting of neighboring genes. Genes Dev. 2006, 20 (10): 1268-82. 10.1101/gad.1416906.
Thakur N, Tiwari VK, Thomassin H, et al: An antisense RNA regulates the bidirectional silencing property of the Kcnq1 imprinting control region. Mol Cell Biol. 2004, 24 (18): 7855-62. 10.1128/MCB.24.18.7855-7862.2004.
Barlow DP: Methylation and imprinting: from host defense to gene regulation?. Science. 1993, 260 (5106): 309-10. 10.1126/science.8469984.
Seitz H, Royo H, Bortolin ML, Lin SP, Ferguson-Smith AC, Cavaille J: A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain. Genome Res. 2004, 14 (9): 1741-8. 10.1101/gr.2743304.
Weidman JR, Murphy SK, Nolan CM, Dietrich FS, Jirtle RL: Phylogenetic footprint analysis of IGF2 in extant mammals. Genome Res. 2004, 14 (9): 1726-32. 10.1101/gr.2774804.
McDonald JF, Matzke MA, Matzke AJ: Host defenses to transposable elements and the evolution of genomic imprinting. Cytogenet Genome Res. 2005, 110 (1–4): 242-9. 10.1159/000084958.
Youngson NA, Kocialkowski S, Peel N, Ferguson-Smith AC: A small family of sushi-class retrotransposon-derived genes in mammals and their relation to genomic imprinting. J Mol Evol. 2005, 61 (4): 481-90. 10.1007/s00239-004-0332-0.
Renfree MB: The composition of fetal fluids of the marsupial Macropus eugenii. Dev Biol. 1973, 33 (1): 62-79. 10.1016/0012-1606(73)90165-6.
Renfree MB: Feto-placental influences in marsupial gestation. Reproduction and Evolution: Aust Acad of Science. Edited by: Calaby JH, Tyndale-Biscoe CH. 1977, 325-31.
Chang TS, Kim MJ, Ryoo K, et al: p57KIP2 modulates stress-activated signaling by inhibiting c-Jun NH2-terminal kinase/stress-activated protein Kinase. J Biol Chem. 2003, 278 (48): 48092-8. 10.1074/jbc.M309421200.
Joseph B, Wallen-Mackenzie A, Benoit G, et al: p57(Kip2) cooperates with Nurr1 in developing dopamine cells. Proc Natl Acad Sci USA. 2003, 100 (26): 15619-24. 10.1073/pnas.2635658100.
Yokoo T, Toyoshima H, Miura M, et al: p57Kip2 regulates actin dynamics by binding and translocating LIM-kinase 1 to the nucleus. J Biol Chem. 2003, 278 (52): 52919-23. 10.1074/jbc.M309334200.
Sakai K, Peraud A, Mainprize T, et al: Inducible expression of p57KIP2 inhibits glioma cell motility and invasion. J Neurooncol. 2004, 68 (3): 217-23. 10.1023/B:NEON.0000033380.08940.c8.
Tyndale-Biscoe H, Renfree MB: Monographs on Marsupial Biology: Reproductive physiology of marsupials. 1987, Cambridge.: Cambridge University Press
Renfree MB: Protein, amino acids and glucose in the yolk-sac fluids and maternal blood sera of the tammar wallaby, Macropus eugenii (Desmarest). J Reprod Fertil. 1970, 22 (3): 483-92.
Jurka J, Klonowski P, Dagman V, Pelton P: CENSOR – a program for identification and elimination of repetitive elements from DNA sequences. Computers and Chemistry. 1996, 20 (1): 119-22. 10.1016/S0097-8485(96)80013-1.
Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 2001, 29 (9): e45-10.1093/nar/29.9.e45.
Nolan T, Hands RE, Bustin SA: Quantification of mRNA using real-time RT-PCR. Nat Protoc. 2006, 1 (3): 1559-82. 10.1038/nprot.2006.236.
Onyango P, Miller W, Lehoczky J, et al: Sequence and comparative analysis of the mouse 1-megabase region orthologous to the human 11p15 imprinted domain. Genome Res. 2000, 10 (11): 1697-710. 10.1101/gr.161800.
Weksberg R, Smith AC, Squire J, Sadowski P: Beckwith-Wiedemann syndrome demonstrates a role for epigenetic control of normal development. Hum Mol Genet. 2003, 12 (Spec No 1): R61-8. 10.1093/hmg/ddg067.
This study was supported by the Australian Research Council Centre of Excellence for Kangaroo Genomics grant, an Australian Postgraduate Award and a Post-Graduate Overseas Research Scholarship, a Drummond Award, and an Albert Shimmins Award from the University of Melbourne to EIA, an Australian Research Council Federation Fellowship to MBR, and a National Health and Medical Research Council RD Wright Fellowship to AJP.
MBR, GS, AJP, EIA, HMG and other members of the Renfree Research Group collected the samples; EIA and HMG performed all the experiments and genome analysis. All authors provided suggestions for the experiments, and read, modified and approved the final manuscript.
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.
About this article
Cite this article
Ager, E.I., Pask, A.J., Gehring, H.M. et al. Evolution of the CDKN1C-KCNQ1 imprinted domain. BMC Evol Biol 8, 163 (2008). https://doi.org/10.1186/1471-2148-8-163
- Repetitive Element
- Imprint Gene
- Antisense Transcript
- Tammar Wallaby
- KCNQ1 Gene